Contract 75N93020P00296
Medix Biochemica USA, Inc. · Department Of Health And Human Services · February 13, 2020
Medix Biochemica USA, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on February 13, 2020 for $17,000 of work in biological product (except diagnostic) manufacturing. Performance is in Maryland Heights, MO. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 16, 2025.
Contract details
- PIID
- 75N93020P00296
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Maryland Heights, MO
- First action
- February 13, 2020
- Latest action
- January 16, 2025
Description
NOVATION
Modification timeline
-
January 16, 2025Mod P00002$0
-
February 19, 2020Mod P00001HUMAN BIOLOGICALS$100
-
February 13, 2020Base awardHUMAN BIOLOGICALS$17.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93020P00296?
Contract 75N93020P00296 is a federal contract awarded to Medix Biochemica USA, Inc. by Department Of Health And Human Services on February 13, 2020 for $17,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75N93020P00296?
Medix Biochemica USA, Inc. won contract 75N93020P00296 from Department Of Health And Human Services.
How much is contract 75N93020P00296 worth?
Contract 75N93020P00296 has obligated $17,000 to date.